PIN6 AN OBSERVATIONAL HEALTH ECONOMIC ANALYSIS OF THE COMBINED THERAPY WITH PEGINTERFERON ALPHA-2A (PEGASYS) AND RIBAVIRIN IN PATIENTS WITH CHRONIC C HEPATITIS (CHC) IN A REAL LIFE SETTING
Abstract
Authors
F Fagnani A Moser A Pinta C Hayem M Bourlire D Ouzan M Deffoel P Marcellin M Vray